古根海姆上调礼来目标价至1036美元

Core Viewpoint - Guggenheim raised the price target for Eli Lilly from $948 to $1036 while maintaining a "Buy" rating [1] Group 1 - The new price target reflects a positive outlook on Eli Lilly's performance in the market [1] - The adjustment indicates confidence in Eli Lilly's growth potential and future earnings [1]